Rob Dillard

DocwireNews

Diabetes appears to play a critical role in the progression from preclinical heart failure (HF) to overt HF, according to a poster presented at the 83rd Scientific Sessions of the American Diabetes Association in San Diego, California.In this analysis, Dr. Justin B. Echouffo Tcheugi, and colleagues assessed 4264 adults (mean age, 76 years; 62% women; 24% Black) with preclinical HF (stage A [n=1174] or B [n=3090]) who attended the Atherosclerosis Risk in Communities Study Visit 5 (2011-2013). Stage A preclinical HF was defined by HF risk factors only. Stage B1 HF was defined as echocardiographic abnormalities but no biomarker elevation; Stage B2 HF was defined as elevated NT-pro-BNP &ge;125 pg/mL and/or hscTnT&gt;14 ng/L but no echocardiographic abnormality; and Stage B3 HF was defined as the presence of echocardiographic and biomarker abnormalities. Researchers assessed the association between diabetes and each preclinical Stage B phenotype with incident HF and HF or death.The researchers observed 383 HF events and 730 deaths over the 8.6 years of follow-up. Their findings linked diabetes with a high absolute risk of HF across all preclinical B stages of HF, but the association was especially strong for the Stage B3 phenotype. Overall, the study showed that individuals with diabetes and Stage B3 HF had the highest risk of HF or HF and death combined. &ldquo;Addressing diabetes appears to be critical in Stage B individuals with both echocardiographic and biomarkers abnormalities for preventing the progression to HF,&rdquo; the researchers concluded.

BMI Modifies the Relationship Between Glycemic Status and Asthma Severity in Children

Asthma

Jordana Jampel

Cutaneous Melanoma: Sun Protection Behaviors and UV Exposure in Canada

Melanoma

Leah Lawrence

Significant Cardiac Benefit Seen With Ifetroban in Patients With Duchenne Muscular Dystrophy

Neurology

Latest News

How Does Diabetes Influence Heart Failure?

American Diabetes Association's 83rd Scientific Sessions

ADA 2023

Diabetes appears to play a critical role in the progression from preclinical heart failure (HF) to overt HF.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe